MTOR and melanoma: Furthermore, downregulation of LKB1 in malignant melanoma specimen, which exhibit activated Akt and overexpression of PLD2, correlates with enhanced mTOR activity, indicating that the mechanism described in this study contributes to pathogenesis of malignant melanoma.